Literature DB >> 32463883

Highlights of the 12th International Bordetella Symposium.

Camille Locht1, Nicholas H Carbonetti2, James D Cherry3, F Heath Damron4,5, Kathryn M Edwards6, Rachel Fernandez7, Eric T Harvill8, Daniela Hozbor9, Kingston H G Mills10, Maria Eugenia Rodriguez11, Françoise Mascart12.   

Abstract

To commemorate the 100th anniversary of the Nobel prize being awarded to Jules Bordet, the discoverer of Bordetella pertussis, the 12th International Bordetella Symposium was held from 9 to 12 April 2019 at the Université Libre de Bruxelles, where Jules Bordet studied and was Professor of Microbiology. The symposium attracted more than 300 Bordetella experts from 34 countries. They discussed the latest epidemiologic data and clinical aspects of pertussis, Bordetella biology and pathogenesis, immunology and vaccine development, and genomics and evolution. Advanced technological and methodological tools provided novel insights into the genomic diversity of Bordetella and a better understanding of pertussis disease and vaccine performance. New molecular approaches revealed previously unrecognized complexity of virulence gene regulation. Innovative insights into the immune responses to infection by Bordetella resulted in the development of new vaccine candidates. Such discoveries will aid in the design of more effective approaches to control pertussis and other Bordetella-related diseases.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Bordetellazzm321990 ; zzm321990 Bordetella genomics; pertussis epidemiology; pertussis vaccines; whooping cough

Mesh:

Substances:

Year:  2020        PMID: 32463883      PMCID: PMC7713684          DOI: 10.1093/cid/ciaa651

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  32 in total

1.  Characterization of adenylate cyclase-hemolysin gene duplication in a Bordetella pertussis isolate.

Authors:  Karine Dalet; Christian Weber; Laurent Guillemot; Elisabeth Njamkepo; Nicole Guiso
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

2.  Appearance of macrolide-resistant Bordetella pertussis strains in China.

Authors:  Zengguo Wang; Yarong Li; Tiejun Hou; Xiaoguai Liu; Ying Liu; Tongtong Yu; Zhijun Chen; Yuan Gao; Hengxin Li; Qiushui He
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

3.  Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the Intermountain West region of the United States.

Authors:  E K Korgenski; J A Daly
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

4.  Lung CD4 Tissue-Resident Memory T Cells Mediate Adaptive Immunity Induced by Previous Infection of Mice with Bordetella pertussis.

Authors:  Mieszko M Wilk; Alicja Misiak; Róisín M McManus; Aideen C Allen; Marina A Lynch; Kingston H G Mills
Journal:  J Immunol       Date:  2017-05-22       Impact factor: 5.422

5.  Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis.

Authors:  J D Cherry
Journal:  Clin Infect Dis       Date:  1999-06       Impact factor: 9.079

6.  Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein.

Authors:  Xavier Préville; Daniel Ladant; Benedikt Timmerman; Claude Leclerc
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

Review 7.  Translocation and calmodulin-activation of the adenylate cyclase toxin (CyaA) of Bordetella pertussis.

Authors:  Alexis Voegele; Darragh P O'Brien; Orso Subrini; Nicolas Sapay; Sara E Cannella; Véronique Yvette Ntsogo Enguéné; Audrey Hessel; Johanna Karst; Véronique Hourdel; Ana Cristina Sotomayor Perez; Marilyne Davi; Rémi Veneziano; Joel Chopineau; Patrice Vachette; Dominique Durand; Sébastien Brier; Daniel Ladant; Alexandre Chenal
Journal:  Pathog Dis       Date:  2018-11-01       Impact factor: 3.166

8.  Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.

Authors:  Dylan T Boehm; Jesse M Hall; Ting Y Wong; Andrea M DiVenere; Emel Sen-Kilic; Justin R Bevere; Shelby D Bradford; Catherine B Blackwood; Cody M Elkins; Katherine A DeRoos; Mary C Gray; C Garret Cooper; Melinda E Varney; Jennifer A Maynard; Erik L Hewlett; Mariette Barbier; F Heath Damron
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

9.  Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis.

Authors:  A Imaizumi; Y Suzuki; S Ono; H Sato; Y Sato
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Bordetella bronchiseptica exploits the complex life cycle of Dictyostelium discoideum as an amplifying transmission vector.

Authors:  Dawn L Taylor-Mulneix; Liron Bendor; Bodo Linz; Israel Rivera; Valerie E Ryman; Kalyan K Dewan; Shannon M Wagner; Emily F Wilson; Lindsay J Hilburger; Laura E Cuff; Christopher M West; Eric T Harvill
Journal:  PLoS Biol       Date:  2017-04-12       Impact factor: 8.029

View more
  2 in total

1.  Down-regulation of miR-340-5p promoted osteogenic differentiation through regulation of runt-related transcription factor-2 (RUNX2) in MC3T3-E1 cells.

Authors:  Xiaochen Wang; Yaochuan Mi; Wei He; Xiaona Hu; Shuo Yang; Lu Zhao; Yanyang Zhang; Binhong Wen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

2.  Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019.

Authors:  Lin T Brandal; Didrik F Vestrheim; Torbjørn Bruvik; Ragnhild B Roness; Martha L Bjørnstad; Margrethe Greve-Isdahl; Anneke Steens; Ola B Brynildsrud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-05-11       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.